Keith Katkin

Current Holdings

Director
Security Holdings
Common Stock 59,872 shares
Director
Security Holdings
Common Stock 65,000 shares

Cumulative Trading Activity in Common Stock for Syndax Pharmaceuticals Inc in 2025

Graph Options

Select a company

Select stock types

This page tracks insider trading for Keith Katkin, which means you can track and be informed when insider trading (i.e., insider trades) occurs. Trading stock is common amongst insiders, and the SEC requires stock trades (such as when individuals buy stock, sell stock, receive stock compensation, etc.) from insiders to be made publicly available. Some people follow the insider market to help them when investing in the stock market (e.g., when deciding whether to buy stocks). On this page, you will see stock trading that Keith Katkin has engaged in since 2022. As shown above, Keith Katkin has completed -$598,768 in total transactions, which were made available through the SEC Form 4, a regulatory filing that makes stock exchange data like this public knowledge.

Found 8 filings

Positive values indicate buys, negative values indicate sales.

Ticker Date Net Cash Net Shares Bought Cash Bought Shares Sold Cash Sold Shares
EBS 2024-5-23 $0 17,430 $0 17,430 $0 0 SEC Filing
SNDX 2024-2-7 $0 17,000 $0 17,000 $0 0 SEC Filing
EBS 2023-5-25 $0 33,847 $0 33,847 $0 0 SEC Filing
SNDX 2023-2-2 $0 16,000 $0 16,000 $0 0 SEC Filing
SNDX 2022-10-6 -$529,234 0 $245,177 29,899 -$774,411 -29,899 SEC Filing
SNDX 2022-9-30 -$69,534 0 $33,243 4,101 -$102,777 -4,101 SEC Filing
EBS 2022-4-2 $0 8,595 $0 8,595 $0 0 SEC Filing
SNDX 2022-2-2 $0 16,000 $0 16,000 $0 0 SEC Filing

The data shown here is based on historical filings with the SEC, and may contain slight inaccuracies.

This data excludes derivative holdings and transactions.

Additional data regarding trading activity for Keith Katkin before the earliest date displayed on this page may exist, but is not shown here.